Back

Anticoagulation/avoid stroke in patients with valvular heart disease.

28 August 2021 (16:10 - 16:23)
Organised by:
Congress Presentation Part of: 2021 ESC/EACTS Guidelines for the management of valvular heart disease Valvular Heart Disease, Other Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Davide Capodanno

University of Catania, Catania (Italy)

4 More presentations in this session

Presentation thumbnail
Timing and indication of intervention in asymptomatic patients with valvular heart disease.
Doctor V. Delgado (Barcelona, ES)
Slides Video
Presentation thumbnail
Mode of intervention in aortic stenosis.
Professor B. Prendergast (London, GB)
Slides Video
Presentation thumbnail
Mode of intervention in mitral regurgitation.
Associate Professor F. Praz (Bern, CH)
Slides Video
Presentation thumbnail
2021 ESC/EACTS Guidelines for the management of valvular heart disease - panel.

Access the full session

Session thumbnail
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 16:10 CET
You may be interested in
thumbnail
Congress Presentation
Anticoagulation in rheumatic multivalvular heart disease: what is new?
27 August 2023
thumbnail
Webinar
Cardiac monitoring after ischaemic stroke: evidence and clinical practice
14 June 2021
thumbnail
Congress Presentation
Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience
2 September 2019
thumbnail
Congress Session
Failing valves and beyond
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources